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The p38 MAPK signaling pathway is essential for skeletal muscle differentiation in tissue culture models. We demonstrate a novel role for p38
MAPK in myogenesis during early Xenopus laevis development. Interfering with p38 MAPK causes distinct defects in myogenesis. The initial
expression of Myf5 is selectively blocked, while expression of MyoD is unaffected. Expression of a subset of muscle structural genes is reduced.
Convergent extension movements are prevented and segmentation of the paraxial mesoderm is delayed, probably due to the failure of cells to
withdraw from the cell cycle. Myotubes are properly formed; however, at later stages, they begin to degenerate, and the boundaries between
somites disappear. Significant apoptotic cell death occurs in most parts of the somites. The ventral body wall muscle derived from migratory
progenitor cells of the ventral somite region is poorly formed. Our data indicate that the developmental defects caused by p38a-knockdown were
mediated by the loss of XMyf5 expression. Thus, this study identifies a specific intracellular pathway in which p38 MAPK and Myf5 proteins
regulate a distinct myogenic program.
D 2005 Elsevier Inc. All rights reserved.Keywords: Myogenesis; Myf5; p38 MAPK; Xenopus laevisIntroduction
Inmammals, it is well established that several factors secreted
in the somite environment initiate the myogenic program
characterized by the activation of two muscle regulatory factors
(MRFs), Myf5 and MyoD (reviewed in Tajbakhsh and Buck-
ingham, 2000). The secreted factors that control myogenesis in
the somite include Sonic hedgehog (Shh), Wnt proteins, bone
morphogenic factors (BMPs) and BMP antagonists such as
Noggin (Buckingham and Cossu, 1997; Cossu and Borello,
1999; McGrew and Pourquie, 1998; Munsterberg et al., 1995).
Although the MRFs are essential for the establishment of
muscle-cell precursors and their differentiation, little is known
about the intracellular signals activating their expression in the
proper time and place during development.
In Xenopus laevis, the expression of XMyf5 and XMyoD
occurs during gastrulation in the presomitic mesoderm region0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.09.020
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dale@tx.technion.ac.il (D. Frank).(dorsal– lateral marginal zone; DLMZ) that subsequently
differentiates to myotomal muscle cells (Hopwood et al.,
1991). The activation of these MRFs in the future muscle
forming region occurs in response to mesoderm inducing
factors like of the FGF, TGFh and Wnt families (Dale and
Jones, 1999; Kimelman and Griffin, 2000; McDowell and
Gurdon, 1999; Shi et al., 2002; Smith, 1995). Other crucial
signaling molecules at these early gastrula stages are BMP
antagonist proteins secreted from the Spemann organizer
region. BMP antagonists dorsalize the DLMZ to muscle
(Harland and Gerhart, 1997; Smith et al., 1993). Dorsalization
of the DLMZ is necessary to preserve XMyoD expression in
this region (Frank and Harland, 1991). BMP antagonism also
induces the MAPK pathway, which increases MyoD protein
levels and converts it into a potent differentiation factor (Zetser
et al., 2001).
While the secreted ligands are known, the intracellular
signaling proteins involved are still relatively unexplored. Cell
culture studies suggest that the intracellular p38 MAPK
pathway is involved in several aspects of myogenic determi-
nation and differentiation. The kinase activity of p38 MAPK is288 (2005) 73 – 86
www.e
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(Cuenda and Cohen, 1999; Zetser et al., 1999). Inhibition of the
pathway by different means completely abolishes in vitro
differentiation (Wu et al., 2000; Zetser et al., 1999). Once
activated, p38 stimulates the activities of MyoD/E47 hetero-
dimers and MEF2 proteins, orchestrating the expression of
many muscle-specific genes (Lluis et al., 2005). Interestingly,
p38 activity facilitates MyoD and MEF2 binding to a subset of
late-activated promoters (Penn et al., 2004). p38 participates in
the transcription of this subset of genes by inducing chromatin
modifications at their loci. p38 activity induces the recruitment
of SWI-SNF remodeling complexes to muscle regulatory
elements (Simone et al., 2004).
The studies of p38 function in myogenic cell lines are
limited to specific stages of myogenesis, and are isolated from
a real developmental context. Therefore, an animal model
system that could study the involvement of p38 MAPK in
early development of skeletal muscle is needed. p38a null
mice developed relatively normally (Adams et al., 2000;
Tamura et al., 2000). The lack of any severe developmental
phenotype might be attributed to the redundant function of
other isoforms of p38, such as p38h, in mice. Thus, double
and/or triple knockout mice strains might be needed in order
to analyze its function. In X. laevis, only two isoforms of p38
are known; p38a (Mpk2) and p38g (SAPK3) (Perdiguero et
al., 2003; Rouse et al., 1994). Cell culture studies have shown
that p38g is probably not involved in the known functions of
this signaling pathway in myogenesis (Cuenda and Cohen,
1999; Wu et al., 2000; Zetser et al., 1999). Therefore, in the
present study, different approaches were used to inhibit p38a
in the developing Xenopus embryo. Interestingly, interference
with the p38 pathway specifically prevented the expression of
XMyf5, but not of XMyoD. Consequently, several defects in
muscle development were observed. At gastrula–neurula
stages, convergent extension cell movements occurring in
paraxial mesoderm were impeded and the expression of
distinct muscle-specific structural genes was reduced. At later
neurula–early tailbud stages, a slight delay in segmentation
occurred. By later tailbud stages, there was a general
deterioration of the somite borders that was a result of
myotube degeneration and massive apoptosis at the ventral
(hypaxial) part of the trunk somites. The loss of migratory
pax3 expressing cells in the hypaxial somite led to poor body
wall muscle formation. Our data indicate that the develop-
mental defects caused by inhibition of p38a were mediated
by the loss of XMyf5 expression. Therefore, this study
delineates a specific intracellular pathway involving p38
MAPK and XMyf5 proteins.
Materials and methods
Embryonic manipulation
Ovulation, in vitro fertilization, embryo culture and dissections were carried
out as described (Re’em-Kalma et al., 1995). Embryos were staged according to
(Nieuwkoop and Faber, 1967). Embryos were taken at different stages and
analyzed for RT-PCR, Western blotting, immunohistochemistry and TUNEL
assays. Ventral marginal zone (VMZ), dorsal– lateral marginal zone (DLMZ)and dorsal marginal (DMZ) explants were removed at stage 10–10.25, and
cultured to different stages as described (Bonstein et al., 1998). In some
experiments, VMZ explants were treated with Noggin and the p38 inhibitor: SB
203580 (30 AM).
Microinjections
Capped synthetic dominant negative MKK6 (DN MKK6) RNA (0.1 ng)
and two morpholino antisense oligonucleotides, Xp38a (5VGACGTAAQ
GATTGATTGGATGACATA3V) and XMyf5 (5VAATGGCAGCTATCQ
TACCATCTCCAT3V) were obtained (Gene Tools) along with a four nucleotide
mismatch control p38a morpholino (5VGACCTAACATTGATTCGATQ
CACATA3V) and injected (7–14 ng) into the marginal zone of one- or two-
cell stage embryos in 0.3 MR containing 3% Ficoll. For rescue
experiments, synthetic capped XMyf5 RNA (Hopwood et al., 1991) was
injected along with the p38a morpholino into the marginal zone of one-cell
stage embryos.
Western blot analysis
Protein extracts were prepared as described (Zetser et al., 2001). Equal
amounts of extracted proteins were loaded (approximately 40 Ag), separated by
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose filters
by standard methods. CREB, phospho CREB, p38, phospho p38 were detected
by polyclonal antibodies (Cell Signaling). Antibody binding was detected using
the Pierce SuperSignal chemiluminescence detection system.
TUNEL staining
Embryos were fixed in MEMFA for 2 h, dehydrated, embedded in paraffin
and sectioned. Transverse sections (5 Am) were treated according to the
supplied protocol (In situ Cell Death Detection Kit, Fluorescein, Roche
Diagnostic, Mannheim, Germany). Nuclear counterstaining was performed
using TO-PRO-3 iodide (Molecular Probes).
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount in situ hybridization was carried out with digoxigenin-
labeled probes (Harland, 1991; Hemmati-Brivanlou et al., 1990; Zetser et al.,
2001). Embryos were cultured to different stages and subsequently fixed for
in situ hybridization. XMyoD (Frank and Harland, 1991), XMyf5 (Hopwood
et al., 1991), pax3 (Martin and Harland, 2001) and muscle actin (Hemmati-
Brivanlou et al., 1990) specific probes were used. Whole-mount immunos-
taining was performed as described (Brivanlou and Harland, 1989).
Hybridoma supernatant of 12/101-mature muscle antigen (Kintner and
Brockes, 1984) was diluted 1:1. Antibody against PCNA (proliferation cell
nuclear antigen) was used at a dilution of 1:250 (DakoCytomation). For
immunohistochemistry on sections, slides were deparaffinized and hydrated
with a decreased alcohol gradient. Then sections were blocked with goat
serum for 1 h following 12 h incubation with the primary antibody (12/101,
PCNA). Slides were incubated with a secondary rhodamine HRP-conjugated
antibody, counterstained with TO-PRO-3 and were visualized by confocal
microscopy.
RT-PCR
RT-PCR was performed as described (Wilson and Melton, 1994), except
that random hexamers (100 ng per reaction) were used for reverse
transcription. Primers for EF1a (Hemmati-Brivanlou and Melton, 1994),
XMyoD (Nicolas et al., 1998), and muscle actin (Wilson and Melton, 1994)
were described. Primers for XMyf5, desmin, MHC, tropomyosin are as follows:
tropomyosin (F 5VTGG AGA TGG CGG AGA AGA AG3V; R 5VGCA GCA
AGT GGC AGT CAC GA3V); MHC (F 5VAGG ACC TGG TGG ACA AAC
TTC A3V; R 5VTAT TGG AGG CAA GAA AGA GTC TGA AG3V); desmin (F
5VCCA GGG TGA ACG AGC TGT AT3V; R 5VTCA ACA TCC CCT CTG
AAA GC3V); XMyf5 (F 5VCTA TTC AGA ATG GAG ATG GT3V; R 5VGTC
TTGGAG ACT CTC AAT A3V).
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p38 MAPK is active in the dorsal–lateral marginal zone
during early muscle determination
To study the possible involvement of p38 MAPK in early
development of skeletal muscle, we compared the phosphor-
ylation status of one substrate, the CREB protein in the
ventral marginal zone (VMZ) and the dorsal–lateral marginal
zone (DLMZ) from gastrula through neurula stages. VMZ and
DLMZ explants were dissected at early gastrula stages, and
cultured until sibling embryos reached neurula stages. Protein
extracts were isolated from explants and CREB was detected
by Western analysis (Fig. 1A). Levels of phosphorylated
CREB were higher in neurula stage DLMZ explants versus
VMZ explants (compare lanes 1 to 2 and 3 to 4). CREB can
serve as a substrate for other kinases, and therefore other
approaches were taken to ascertain that p38 MAPK was
involved. We analyzed the phosphorylation status of p38
MAPK itself (Fig. 1A, right panel). A battery of commercial
anti phospho p38 antibodies were analyzed (not shown), and
only one weakly identified the protein. Still, we could
consistently show that the phosphorylated form of p38 was
found in the DLMZ, and not in the VMZ (right panel). In
other experiments, VMZ explants were isolated at early
gastrula stages and treated with Noggin, and SB203580, a
p38 a/h inhibitor (see Fig. 1B). Noggin dorsalization of VMZ
explants induced the phosphorylation of CREB relative to
control VMZ explants. Cotreatment of explants with NogginFig. 1. p38 MAPK and its substrate CREB are phosphorylated in DLMZ but
not in VMZ explants. (A) VMZ and DLMZ explants were dissected at stage
10.25, and cultured until sibling embryos reached later gastrula and neurula
stages as indicated. Proteins were extracted from 18 explants and CREB,
phospho CREB (pCREB), a tubulin, p38 and phospho p38 (pp38) were
detected by Western analysis. The asterisk represents an unidentified cross-
reacting protein. (B) VMZ explants were isolated at stage 10+, incubated with
Noggin or SB203580 (30 AM) and cultured until sibling embryos reached stage
16. Proteins were extracted from 18 explants. CREB and phospho CREB were
detected by Western blotting.and SB203580 inhibited CREB phosphorylation, suggesting
the involvement of p38 MAPK. Overall, these results indicate
that p38 MAPK is active in the DLMZ during the early stages
of muscle specification.
Inhibition of p38 MAPK prevents the expression of XMyf5 but
not of XMyoD
The functional role of p38 MAPK in myogenesis was
explored. Three different approaches were used to block p38
MAPK activity in explants and embryos. In the first, VMZ
explants were isolated at early gastrula stages and dorsalized by
Noggin treatment. A pharmacological inhibitor of p38 MAPK,
SB203580 was added to these explants. In the second
approach, embryos at the one-cell stage were injected with
RNA encoding an inactive form of MKK6 (DN MKK6), the
direct kinase of p38 MAPK. MKK6 expression was verified by
Western analysis of extracts from the injected embryos (Fig.
2A2, lower panel). In the third approach, embryos were
injected with a p38a MAPK antisense morpholino (p38a
MO) or with a control morpholino (p38a CMO). A substantial
decrease of p38 protein levels in p38a MO-injected embryos
was observed by Western analysis (Fig. 2A3, lower panel). To
confirm that p38 activity was also affected in these embryos, an
in vitro kinase assay was performed (Supplementary Fig. S1).
Kinase activity of p38 in extracts from p38a MO-injected
embryonic DLMZ explants was significantly lower than in
control explants. Next, DLMZ explants were isolated from
injected embryos at early gastrula stages and cultured until
sibling embryos reached neurula stages. RNA was extracted
and the expression of MRFs was analyzed by RT-PCR (Fig.
2A). Using all three p38 inhibitors, we found substantially
lower levels of XMyf5 transcripts in treated embryos relative to
control embryos. The levels of XMyf5 transcripts were not
changed in p38a CMO-injected, relative to control embryos. In
contrast to XMyf5, levels of XMyoD transcripts were un-
changed in these experiments, suggesting that p38 MAPK
selectively affects XMyf5 and not XMyoD. The levels of muscle
actin were only marginally reduced in treated embryos relative
to controls. Our experiments indicate that DN MKK6 and p38a
MO caused identical myogenic phenotypes, thus we chose to
present p38a MO knockdown experiments.
To determine if p38-knockdown affected early expression of
XMyf5, embryos were injected into one-cell stage embryos
with the p38a MO. XMyoD and XMyf5 expression was
examined at late gastrula–early neurula stages (Fig. 2B). The
expression of XMyf5 is significantly reduced in the injected
embryos (90% of injected embryos did not express detectable
levels of XMyf5, n = 40; Fig. 2B, lower panels) in comparison
to the uninjected control embryos (90% expressed XMyf5,
n = 62). The expression of XMyoD was robust in both injected
and uninjected control embryos (Fig. 2B, upper panels). To
further analyze the expression of these MRFs during later
stages of development, both blastomeres of two-cell stage
embryos were injected with the p38a MO, and embryos were
grown to tailbud stages and examined for XMyoD and XMyf5
expression (Fig. 2C). In uninjected controls, XMyf5 expression
Fig. 2. Inhibition of p38 blocks the expression of XMyf5 without affecting XMyoD expression. (A) 18 VMZ explants were dissected at stage 10.25 from control
embryos and incubated with Noggin and SB (30 Am) [1]. In parallel, embryos at the one-cell stage were injected with 0.5 ng of in vitro transcribed DN MKK6
mRNA [2], or with 7.5 ng of p38a antisense morpholino (p38a MO), or with 7.5 ng of control antisense morpholino (p38a CMO) [3]. At stage 10.25, 18 DLMZ
explants were dissected from control and treated embryos. Explants were cultured until sibling embryos reached early neurula stages, and total RNAwas isolated. RT
PCR analysis was preformed with primers to XMyf5, XMyoD, muscle actin and EF1a serving as a control for quantifying RNA levels of different samples. Control-
RT PCR was also performed (not shown). For Western analysis, DLMZ explants from p38a MO, DN MKK6-injected and control embryos were cultured until
sibling embryos reached later gastrula stages. Proteins were extracted from explants. Antibodies to HAwere used to detect ectopic DN MKK6 protein, and antibodies
to p38, to detect endogenous p38a protein. (B, C) Expression patterns of the myogenic transcription factors XMyf5 and XMyoD at different developmental stages.
One-cell stage embryos were injected with p38aMO. At stages 13 (B) and 23/24 (C), embryos were fixed and analyzed for the expression of XMyoD and XMyf5 by
whole-mount in situ hybridization. (B) 92% of control embryos were expressed XMyoD (n = 51) and 94% of the p38aMO-injected embryos expressed XMyoD (n =
35). 90% of control embryos expressed for XMyf5 (n = 62) and only 20% of the p38a MO-injected embryos expressed XMyf5 (n = 40). Dorsal view, anterior-top.
(C) 93% of control embryos expressed XMyoD (n = 30) and 90% of p38a MO-injected embryos expressed XMyoD (n = 27). 97% of control embryos expressed
XMyf5 in the somites (n = 35) and 16% of p38a MO-injected embryos were stained for XMyf5 in the somites (n = 40). Anterior-left.
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stained throughout the somites in a distinct segmental pattern
(Martin and Harland, 2001). In most p38a MO-injected
embryos, XMyf5 staining was specifically affected while
XMyoD was not, relative to controls (Fig. 2C). Knockdown
of p38 MAPK reduced anterior somitic staining of XMyf5,
while it did not affect posterior presomitic staining. These
results suggest that p38 MAPK is needed for the initial
expression of XMyf5 during gastrulation and also for later
expression in the somites, but not in the tail. This observation
indicates that p38 MAPK function may be limited to distinct
myogenic programs in Xenopus development (Nicolas et al.,
1998).
Knockdown of p38 MAPK prevents convergent extension of the
paraxial mesoderm
Embryos depleted of p38 MAPK underwent cleavage and
gastrulation normally, suggesting that p38 was not required for
early embryonic development. However, as development
continued, several defects became apparent. By stage 25,
control embryos had developed an elongated shape, while
treated embryos failed to completely elongate along the
anterior–posterior axis (data not shown). The reduced embryo
body length could be caused by a defect in mesoderm inductionFig. 3. Inhibition of p38 reduces convergent extension of presomitic mesoderm.
dissected at stage 10.25 and cultured until sibling embryos reached early neurula sta
with p38aMO in one blastomere at the two-cell stage, were immunostained, using th
presomitic and somitic mesoderm (12/101) and blue represents nuclei staining (TO-P
with all five embryos.or by a defect in convergent extension. The first possibility
seemed unlikely, as we observed no major differences in the
levels of XMyoD expression in p38-knockdown embryos
relative to control embryos (Fig. 2). Furthermore, the early
differentiation of paraxial mesoderm into muscle tissue
appeared normal in treated embryos, as judged by the
expression of muscle actin (Fig. 2A). We then examined
convergent extension by comparing the ability of DLMZ
explants to elongate. Knockdown of p38 MAPK activity
significantly reduced elongation of DLMZ explants relative to
control explants (Fig. 3A, upper panels). In p38-knockdown
embryos, DMZ explants elongated in a normal manner, similar
to control DMZ explants (Fig. 3A, lower panel). In later stages
of development, notochord development also appears normal
in p38-knockdown embryos (data not shown). Therefore, the
loss of convergent extension appears to be specifically
restricted to muscle-fated paraxial and not notochord-fated
axial mesodermal regions of the embryo.
The defect in convergent extension could also be observed by
detecting XMyoD expression in embryos (Fig. 2B). XMyoD is
expressed symmetrically along the anterior–posterior axis, with
its expression extending laterally at the posterior end (Fig. 2B).
The XMyoD expression pattern is more laterally broadened,
being positioned at a farther distance from the dorsal midline in
p38a MO-injected embryos compared to control embryos. The(A) Embryos were injected with p38a MO. DLMZ and DMZ explants were
ges. (B) Longitudinal sections of embryos (n = 5) at stages 16 and 22, injected
e 12/101 antibody and viewed by confocal microscopy. Red staining represents
RO3 iodide). Results shown are from one embryo. Similar results were obtained
Fig. 4. Inhibition of p38 prevents cell cycle arrest in the presomitic mesoderm
Two-cell embryos were injected unilaterally into one blastomere with p38aMO
(7.5 ng). Embryos were cultured until late gastrula-early neurula stages, then
fixed and longitudinally-sectioned. Proliferation cell nuclear antigen (PCNA
antibody was used to detect nuclei of proliferating cells (red staining). Nuclea
counterstaining was done with TO-PRO3 iodide (blue staining). Section of one
embryo is shown. Similar results were obtained with all other embryos (n = 4)
Statistical analysis from the four embryos is presented.
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blocks is wider and it appears that these cells have not undergone
proper medial intercalation towards the dorsal midline during
gastrulation. p38aMO embryos were also about 15% shorter in
length at these stages, in comparison to control embryos (Fig.
2B). Similar XMyoD expression patterns were seen in paraxial
mesoderm in which convergent extension was inhibited by Ca+2
channel blockers or by preventing cell cycle arrest (Leise and
Mueller, 2004; Wallingford et al., 2002).
Another distinct consequence of p38-knockdown was
observed at later neurula–tailbud stages, when somites begin
to form. To view the forming somites, embryos were
longitudinally-sectioned, and immunostained with the 12/101
antibody (Fig. 3B). At stage 16 (left panel), the mesoderm of
the MO-treated side has not extended anteriorly as that of the
control side. Additionally, one somite has formed on the
control side, while in the MO-injected side, the presomitic
mesoderm (PSM) has not segmented yet. Later, at stage 22,
somites are formed on the p38a MO-injected side, though in a
delayed manner relative to the control side (right panel). The
first somite of the MO-injected side is aligned with the second
somite on the control side of the embryo. Overall, it appears
that the process of PSM segmentation is normally initiated in
the MO-injected side of the embryo, although the process is
delayed relative to the uninjected control side.
Knockdown of p38 prevents cell cycle arrest
It is well established that mesoderm cells stop dividing with
the onset of gastrulation through neurulation as the dorsal
mesoderm delineates into axial and paraxial mesoderm (Hard-
castle and Papalopulu, 2000; Saka and Smith, 2001). The
paraxial mesoderm re-enters the cell cycle only after a somite
has formed (Saka and Smith, 2001). Recently, it was shown
that cell cycle withdrawal during these developmental stages is
required for convergent extension and somitogenesis of the
paraxial mesoderm (Leise and Mueller, 2004). Therefore, we
analyzed whether the knockdown of p38 affected the cell cycle
of paraxial mesoderm during early neurula stages. Two-cell
stage embryos were unilaterally injected to one blastomere with
p38a MO; embryos were cultured to stage 15, longitudinally-
sectioned, and dividing cells were detected by their positive
immunostaining with antibodies to PCNA (Fig. 4). In
agreement with previous studies, most of the cells within the
paraxial mesoderm of the uninjected control side (right of the
dashed line) did not stain for PCNA, suggesting that they were
resting cells. In sharp contrast, most of the cells within the
paraxial mesoderm on the p38a MO-injected side (left of the
dashed line) positively stained for PCNA. Additionally, the
higher absolute number of nuclei in the MO-injected side
relative to the control side indicates the differences in cell
division between the two sides of the embryo (Fig. 4). Thus,
we can conclude that p38 MAPK is most likely involved in cell
cycle withdrawal in the paraxial mesoderm during gastrula to
neurula stages. Cell proliferation caused by reduced p38 levels
could explain the defects in convergent extension and the delay
in somitogenesis (Leise and Mueller, 2004)..
)
r
.Loss of somitic boundaries occurs at tailbud stages in embryos
injected with the p38a antisense morpholino
Results presented in Fig. 3B suggest that the initial
segmentation of somites in the MO-injected side of embryos
occurs fairly normally, though delayed relative to the control-
uninjected side. Next, we examined somite morphology and
muscle fiber structure at later tailbud stages. In whole-mount
staining of muscle actin, the segmental pattern of the somites is
clearly detected in control embryos (Fig. 5A, upper panel). In
contrast, somite boundaries cannot be detected in those
embryos injected with the p38a MO. Loss of somite
boundaries could be the outcome of an abnormal structure of
the myofibers. To view myofibers, longitudinal sections of the
same stage embryos as above were immunostained with an
antibody to skeletal muscle specific antigen, 12/101 (Fig. 5A,
lower panel). Myofibers of control embryos extend from one
somite boundary to the next in a parallel orientation, and their
staining is intense and uniform. In p38-knockdown embryos,
the intensity of staining is much weaker and boundaries
between somites can no longer be detected (Fig. 5A, lower
panel). This abnormal staining indicates that myotubes may be
damaged in MO-injected embryos. To view myotubes at a
better resolution, longitudinal sections were immunostained
with muscle-specific antibodies (Fig. 5B). Myotube diameter
and the intensity of staining are significantly higher in controls
versus p38-knockdown embryos. Overall, these data indicate
that myotubes are formed, though specific deficiencies may
account for defects in myotube structure in p38-knockdown
embryos. Since the expression of XMyf5, but not of XMyoD is
reduced in the p38-knockdown embryos, we hypothesized that
Fig. 5. Somite boundaries and myotube structure are disrupted in p38a-knockdown embryos. (A) Embryos (n = 15) were injected with p38aMO and cultured until
they reached stage 25. Embryos were fixed and taken for whole-mount in situ hybridization for detecting muscle actin (upper panel). Somite patterning was observed
on longitudinal sections immunostained with the 12/101 antibody and analyzed by confocal microscopy (lower panel) (n = 7). (B) Longitudinal sections of MO-
injected and uninjected embryos (stage 25) were immunostained with the 12/101 antibody and analyzed under light microscopy (n = 6). Double arrows show
myotube diameter. (C) 18 DLMZ explants were removed from each uninjected and p38a MO-injected embryos and cultured until sibling embryos reached stage 18
and RNA was isolated. RT-PCR analysis was preformed with primers to MHC, desmin, tropomyosin, muscle actin and EF1a serving as a control for quantifying
RNA levels in the different samples. Control-RT PCR was performed (not shown). All injected embryos in panels A and B displayed similar phenotypes.
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could be affected in these embryos. Hence, the expression of
several structural genes was compared between control and
p38-knockdown embryos. Whereas, the expression of muscle
actin and myosin heavy chain was comparable, the levels of
desmin and tropomyosin were lower in p38-knockdown
embryos, relative to controls (Fig. 5C). Expression levels of
tropomyosin and desmin were not affected in embryos injected
with the control morpholino. These results suggest that p38
MAPK is involved in the expression of distinct muscle
structural genes. Lower expression of certain muscle structuralproteins may explain the defects in myotube structure observed
in p38-knockdown embryos.
Cells in large parts of the somite undergo apoptotic cell death
in p38a MO-injected embryos
In other model systems, it was shown that defects in
myoblast cell cycle withdrawal and abnormal expression of
structural genes could lead to apoptosis and muscle degener-
ation (Walsh and Perlman, 1997). The relatively low myofiber-
staining (Fig. 5) suggests that apoptotic cell death could be
A. Keren et al. / Developmental Biology 288 (2005) 73–8680occurring in the somites of p38a MO-injected embryos.
Therefore, we analyzed apoptotic cell death in the somites, at
the same developmental stages (Fig. 6A). TUNEL staining of a
transverse section shows that significant apoptosis occurs in the
somites of the p38a MO-injected half, but not in the control
half of the embryo. Specifically, the majority of TUNEL-
positive cells are concentrated in the ventral half of the somite,Fig. 6. The ventral portions of the somite undergo apoptotic cell death in tailbud p38
blastomere with p38aMO (7.5 ng). Embryos were cultured to stage 25. Four embryo
TRO-PRO3 staining. One sectioned embryo is shown. Similar results were obtained
blue. Approximate somite borders are schematically presented. Som. is somite and N
p38a MO (7.5 ng). Embryos were cultured to stage 31. Injected embryos were
immunostained with the 12/101 antibody (red staining) followed by TRO-PRO3 s
obtained with all other embryos (n = 5). (C) Embryos were injected with p38aMO. E
muscle actin. Arrows point at migrating muscle progenitor cells. Embryos were i
immunostained with the 12/101 antibody and analyzed by light microscopy. Arrowwhile the dorsal part is unaffected (Fig. 6A). Interestingly, at
tailbud stages, the expression of XMyf5 is restricted to the
dorso-medial and ventro-lateral lips of the somites (Martin and
Harland, 2001), suggesting that apoptosis is not completely
overlapping the regions of XMyf5 expression.
To further analyze the consequences of the apoptotic
process at these particular somitic regions, stage 31 embryos-knockdown embryos. (A) Two-cell embryos were injected unilaterally into one
s were transversely-sectioned and TUNEL analysis was performed followed by
with all other embryos (n = 4). Cells undergoing apoptosis are stained in light
.T is neural tube. (B) Two cell embryos (n = 5) were injected unilaterally with
longitudinally sectioned at different dorso-ventral levels of the somites and
taining (blue staining). One sectioned embryo is shown. Similar results were
mbryos were fixed and taken for whole-mount in situ hybridization to pax3 and
njected with p38a MO and cultured to stage 46. Whole embryos were fixed,
s point at muscle cells (lower panel).
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of the somites and immunostained to detect myofibers (Fig.
6B). The severity of defects in myofibers is correlated with the
degree of apoptosis in the different planes of the somite. Very
weak muscle staining and disorganized muscle fibers are
observed in the ventral plane of the somite (lower panel). The
defects are much less pronounced in the medial and dorsal
planes. Thus, the most severe effects of p38-knockdown are
massive apoptotic cell death and muscle fiber degeneration,
which occur in the ventral half of the somite where XMyf5 is
normally expressed.
The ventral body wall muscle is formed in Xenopus from
migratory precursors originating in the ventral part of the
somite (Martin and Harland, 2001). As muscle cells in this
region of the somites undergo extensive apoptosis in p38-
knockdown embryos, one would expect that muscle precursor
migration to form the ventral body wall might be affected.
The ventral migratory precursors can be identified as pax3-
expressing cells (Martin and Harland, 2001). Expression of
pax3 is almost absent in the same region of embryos injected
with p38a MO, in comparison to controls (Fig. 6C). The
migratory pathway of muscle cells from the hypaxial somite
towards the ventral body plain was viewed by whole-mount
staining of muscle actin in tadpole stage embryos (Fig. 6C).
Clusters of muscle actin-expressing cells (marked by arrows
in the figure) are found in between the somites and ventral
region of control embryos. These clusters are almost
completely absent in the embryos injected with p38a MO,
suggesting that the formation of migratory expressing pax3
muscle precursors was prevented. At later stages when ventral
muscle wall is already formed in wild type embryos (lower
panel, control), very few myofibers are stained in MO-
injected embryos. Therefore, the robust apoptosis and
degeneration of muscle fibers in the ventral portion of the
somite are the likely causes for absence of precursor cell
migration and formation of ventral muscle wall in p38-
knockdown embryos.
Exogenous expression of XMyf5 rescues the phenotype
mediated by p38-knockdown
The observation that levels of XMyf5, but not of XMyoD
were reduced in p38-knockdown embryos raised that
possibility that the muscle phenotypes of these embryos
were mediated by the absence of XMyf5 expression. For
investigating this possibility, we microinjected both blasto-
meres of two-cell stage embryos with an XMyf5 antisense
morpholino oligonucleotide (XMyf5 MO). First, we examined
convergent extension by comparing the ability of DLMZ
explants to elongate. Knockdown of Myf5 significantly
reduced elongation of DLMZ explants (Fig. 7A). Next,
XMyf5-knockdown embryos were cultured to stage 30 and
the somites were identified by whole-mount staining of
muscle actin (Fig. 7B). Muscle actin expression levels were
similar in both control and XMyf5 MO-injected embryos,
though the segmental pattern of the injected embryos was
eliminated relative to controls. We also analyzed theexpression of several muscle-specific structural genes (Fig.
7C). The expression of muscle actin and MHC was
unaffected, though expression of desmin and tropomyosin
was reduced in embryos injected with XMyf5 MO relative to
control embryos. This expression profile is identical to that
of embryos injected with p38a MO (compare Fig. 7C to
5C). Finally, we analyzed apoptotic cell death in the somites
of XMyf5 MO-injected embryos by TUNEL staining of
cross-sectioned embryos (Supplementary Fig. S2). Like in
p38-knockdown embryos, significant apoptosis occurred in
the somites of the XMyf5 MO-injected half, but not in the
control half of the embryos. Therefore, it appears that all
aspects of the phenotype of XMyf5-knockdown analyzed are
similar to that of p38-knockdown.
To further explore the involvement of Myf5 in the
phenotype of p38-depleted embryos, we determined whether
ectopic expression of XMyf5 could restore normal development
to these embryos (Fig. 7D). Injection of the p38a MO
prevented the segmental pattern of somites seen in control
embryos (compare middle to left panel). Embryos, coinjected
with XMyf5-encoding RNA and the p38a MO showed a very
distinct segmental pattern; they appeared identical to control
embryos. Next, we analyzed whether the ectopic expression of
XMyf5 could restore the expression of specific skeletal muscle
genes (Fig. 7D, lower panel). The repressed expression of
desmin and tropomyosin in p38-knockdown embryos was
restored in embryos injected with XMyf5 mRNA. Therefore,
we can conclude that XMyf5 is a major downstream target of
the p38 MAPK signaling pathway in muscle development.
Discussion
In this study, we have identified a unique role for the p38
MAPK signaling pathway in embryonic muscle cell formation.
Knockdown of p38 affects very specific aspects of skeletal
muscle formation and maintenance, but not the overall process
of mesoderm or muscle cell induction. This result is quite
surprising, since p38 levels are likely reduced in all tissues,
while the effects are specific to muscle.
p38 MAPK and XMyf5 expression
In p38-knockdown embryos, XMyf5 expression was highly
reduced in late gastrula stage mesoderm, yet XMyoD
expression was not altered. The expression of XMyf5 initiates
at early gastrula stages prior to the expression of XMyoD.
XMyf5 expression is restricted in two symmetrical dorso-
lateral domains (Dosch et al., 1997), whereas early gastrula
expression of XMyoD occurs in the entire marginal zone with
the exception of the dorsal domain (Frank and Harland,
1991). Later in development, during somitogenesis, XMyf5
expression is restricted to the posterior somites and the tail,
while XMyoD is expressed in more mature anterior somites
(Dosch et al., 1997). Their expression within the somites is
also different; XMyoD is expressed throughout the myotome,
while XMyf5 expression is restricted to the most ventral and
dorsal regions of the somite (Martin and Harland, 2001).
Fig. 7. Exogenous expression of XMyf5 rescues the phenotype of p38-knockdown embryos. (A) Embryos were injected with XMyf5 MO. DLMZ explants were
dissected at stage 10.25 and cultured until sibling embryos reached early neurula stages. (B) Embryos were injected with XMyf5 MO and cultured to tadpole stage.
Embryos were fixed and taken for whole-mount in situ hybridization using a probe of muscle actin. 95% of control embryos displayed segmental phenotype (n = 38).
92% of MO-injected embryos lost the segmented phenotype (n = 41). (C) Embryos were injected with the XMyf5 MO. 18 DLMZ explants were dissected at stages
10.25 and cultured until sibling embryos reached early neurula stages (stage 18). RNAwas isolated and RT PCR analysis was performed with primers toMHC, desmin,
tropomyosin, muscle actin and EF1a serving as a control for quantifying RNA levels in each sample. Control-RT PCR reactions were performed (not shown). (D)
Embryos were injected with XMyf5-encoding RNA (0.8 ng), and p38aMO and cultured until control embryos reached stage 29/30. Embryos were fixed and analyzed
by whole-mount in situ hybridization using themuscle actin probe (upper panel). Statistical analysis relates to the percentage of embryos displaying normal segmented
phenotypes. Embryos were injected as described above. 18 DLMZ explants were dissected at stages 10.25 and cultured until sibling embryos reached early neurula
stages (stage 18). RNA was isolated and RT PCR analysis was performed with primers to desmin, tropomyosin, muscle actin and EF1a (lower panel).
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XMyf5 and XMyoD expression. Moreover, in this work, we
show that p38 MAPK controls the more anterior somite
expression of XMyf5, but not its expression in the tail (Fig.
2C). Thus, this study identifies an intracellular pathway in
which p38 MAPK modulates specific temporal and spatial
expression of XMyf5.
Our observations strongly suggest that all of the myogenic
phenotypes observed in p38-knockdown embryos could be
attributed to the lack of XMyf5 expression (Fig. 7). Supportingour results, in zebrafish embryos, injection of Myf5 MO caused
a very similar phenotype. In these embryos, convergent
extension was inhibited, somites were abnormally patterned,
desmin expression was reduced, yet MyoD expression was
normal (Chen and Tsai, 2002).
One obvious next goal would be to investigate how p38
MAPK regulates the expression of XMyf5. One approach is to
study the possible cross-talk of p38 MAPK with other
signaling molecules affecting the expression of XMyf5.
Previous studies in Xenopus suggested that the XMyf5 gene
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It will be interesting to determine the epistatic relationship
between p38 and wnt signaling in regulating XMyf5 expression
and subsequent muscle formation. Myf5 expression has
recently been demonstrated to be regulated by CREB protein
in a wnt-dependent manner during mouse myogenesis (Chen et
al., 2005). We show that p38 activity is required for CREB
protein phosphorylation (Fig. 1). Thus, it is tempting to
speculate that p38 and wnt-signaling pathways could converge
and regulate the overall levels of activated CREB protein
required for embryonic Myf5 expression.
A second approach is to investigate the regulatory
sequences of the XMyf5 promoter. The XMyf5 promoter region
has been mapped in X. laevis and tropicalis (Polli and Amaya,
2002). Several transcriptional activators and repressors are
involved in the precise temporal expression of XMyf5.
Interestingly, a TCF binding site suggesting the involvement
of the canonical wnt pathway was identified in distal regulatory
sequences of XMyf5 (Yang et al., 2002). However, the site
which binds XTcf3 protein mediates repression of XMyf5
transcription in the dorsal and ventral midline, but does not
contribute to its activation. Thus, it cannot explain how the wnt
pathway may activate the transcription of XMyf5. Other studies
suggest that Vent1 protein functions to repress XMyf5
expression in the ventral domain of the marginal zone (Polli
and Amaya, 2002). Vent1 expression in the marginal zone
region is highly regulated during gastrulation (Gawantka et al.,
1995), and perhaps p38 signaling represses the expression of
the Vent1 gene, thus enabling XMyf5 expression only in the
dorsal lateral mesoderm. T-box proteins have been shown to
activate transcription of the XMyf5 gene (Lin et al., 2003) and
could be potential targets for p38 signaling. Identification of
p38 responsive cis-elements in the XMyf5 promoter would
surely unravel the pathway connecting p38 signaling to early
muscle development.
Convergent extension movements of paraxial mesoderm are
affected by p38 and XMyf5
One of the earliest effects of p38-knockdown was the
failure of gastrula-stage DLMZ explants to efficiently
elongate, suggesting that convergent extension movements,
characteristic of these presomitic mesoderm cells were
disrupted (Fig. 3). The typical cell cycle arrest observed in
gastrula–neurula stage paraxial mesoderm cells was also lost
(Fig. 4). Cell cycle withdrawal was demonstrated to be
essential for proper convergent extension and somitogenesis
in paraxial mesoderm (Leise and Mueller, 2004). In other
cellular systems, p38 was shown to be an important regulator
of cell cycle withdrawal (Ambrosino and Nebreda, 2001).
Therefore, during these specific stages, p38 MAPK may
function to arrest cell cycle via the cell cycle machinery. Cell
cycle regulatory proteins, such as p27Xic1 and the Wee2 cdk
inhibitors play a crucial role in early Xenopus muscle
formation (Leise and Mueller, 2004; Vernon and Philpott,
2003). Depletion of the Wee2 protein in Xenopus embryos
prevented cell cycle arrest and allowed continued proliferationof paraxial mesoderm cells (Leise and Mueller, 2004). These
embryos displayed poor convergent extension, elongation and
somitogenesis. Hence, p38 and Wee2 knockdowns cause
strikingly similar phenotypes. It will be interesting to
investigate how the p38/XMyf5 pathway communicates with
proteins of the cell cycle machinery. The finding of this study
that XMyf5-knockdown reduced DLMZ elongation indicates
that p38 MAPK activity in convergent extension is mediated
by XMyf5. The involvement of XMyf5 in convergent
extension movements could be mediated by its transcriptional
activity. For example, activation of p27Xic1 and/or Wee2
transcription could link XMyf5 to the prerequisite cell cycle
exit, necessary for these cellular movements.
Segmentation is delayed in p38-knockdown embryos
In p38-knockdown embryos, segmentation of PSM occurred
fairly normally, though in a delayed manner (Fig. 3B). This
finding suggests that the segmentation clock which acts in the
PSM behaves normally. Thus, cyclic expression of components
of the Notch signaling pathway (Jen et al., 1997, 1999) is
probably not affected by p38 MAPK. However, the delay in
segmentation might be explained by high local concentrations
of FGF8 at the anterior-most region of the PSM. FGF8 is
expressed in the paraxial mesoderm in Xenopus (Monsoro-
Burq et al., 2003). Normally, FGF8 is secreted at the posterior
end of the PSM, and a gradient of this morphogen is created
from the posterior end to the anterior boundary of the PSM
(Pourquie, 2003). It was proposed that because of the
progressive decrease of FGF8 expression during maturation
of the PSM, when cells become located in the anterior PSM,
they reach a threshold of FGF signaling allowing them to
activate their segmentation program. Delay in segmentation
could therefore be a result of an inhibitory concentration of
FGF8 at the anterior PSM. Defected elongation of p38-
knockdown embryos along the A–P axis could affect a
FGF8 gradient, creating high levels of FGF8 concentrations
at the anterior PSM and thus delaying segmentation.
Muscle degeneration in the ventral region of somites in
p38-knockdown embryos
At tailbud stages, somite boundaries were blurred in p38-
knockdown embryos. Myofiber staining was weaker and
disorganized in comparison to controls; myotube diameters
were also reduced. These results together with muscle staining
at earlier neurula stages suggest that differentiation may occur
normally, and the defects observed were in the maintenance of
muscle fibers. Muscle degeneration could be a consequence of
incomplete withdrawal from the cell cycle (Walsh and Perlman,
1997), and/or the improper expression of desmin and tropo-
myosin. Disruption of Desmin and Vimentin protein function in
intermediate muscle filaments was shown to perturb inter-
somite junction (ISJ) organization in tadpole stage embryos
(Cary and Klymkowsky, 1995). Desmin was shown to be
associated with the periphery of the Z-disk and enriched at the
ISJ where it functions to couple the myofibrils to the
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function of Desmin at the ISJ may explain the limited effects
of its reduced levels on myofiber structure. Still, the specific
defects and lack of mechanical support may lead to the
significant elevated levels of apoptosis observed in the ventral
portions of the somite.
Interestingly, the most highly disorganized myofiber struc-
ture and significant apoptosis occur mainly in the ventral
regions of the somites normally expressing XMyf5. However,
apoptotic cell death occurs in other somitic areas located
outside regions of XMyf5 expression (Martin and Harland,
2001). The extensive apoptosis occurring throughout large
regions of the somite could be a late and secondary effect of
XMyf5 expression loss that occurred in earlier developmental
stages.
Is the Xenopus model universal?
A recent study analyzing the role of p38 in somite culture
and mouse embryos came to the conclusion that p38 signaling
affected MEF2 transcription factors and muscle cell differen-
tiation, but not the expression of Myf5 (de Angelis et al.,
2005). They suggest that p38 is not involved in the initial
commitment of the myogenic lineage, and the conclusions
made in this study are in agreement with several cell culture
studies (Puri et al., 2000; Zetser et al., 1999). However, the
cellular models can only undergo the terminal differentiation
stage, and as such cannot really serve as model systems to
study the possible affects of p38 on myogenic cell lineage
commitment. Still, the question remains as to whether p38
regulates muscle differentiation in Xenopus embryos in a
similar manner to other experimental systems. We cannot
confirm if terminal differentiation was not effected in our
system, since the elimination of XMyf5 expression could mask
downstream effects. This possibility can neither be excluded,
since we did not address this question in the present study.
Although, p38 regulated XMyf5 expression, it could also
modify the transcriptional activities of other MRF and MEF2
proteins. If indeed terminal differentiation was also affected,
then, how could the ectopic expression of XMyf5 restore a
normal muscle phenotype to the p38-knockdown embryos?
One possible explanation is that over-expression of MRFs like
Myf5, could compensate for the limited activities of Myf5 or
other MRFs. In contrast to our study, de Angelis et al. failed to
observe that p38 inhibition reduced Myf5 expression. There are
several major differences between the experimental systems
that could explain this discrepancy. First, their work uses the
pharmacological inhibitor SB203580 as the sole means to
inhibit p38 in explants and whole embryos, whereas we used
several approaches to inhibit p38 activity. Disadvantages of
pharmacological inhibitors are their toxicity and limited
penetration, especially when working with three-dimensional
explants and whole embryos. The effect of SB203580 on Myf5
expression was weaker than the effect of other methods used in
our present work (see Fig. 2A). Thus, one cannot exclude that
limited tissue penetration could explain only partial inhibition.
A second major difference is the developmental stagesanalyzed; in this work, p38 inhibition was initiated from
one-cell to gastrula stages in intact embryos and explants. In de
Angelis et al., inhibition was initiated at the 20–25 somite
stage (9.5 dpc). The initiation of Myf5 expression occurs at
very different developmental stages in mouse and Xenopus.
Thus, differences in temporal Myf5 expression could reflect
changes in Myf5 transcriptional regulation between the two
systems. Future studies should uncover such differences, if
they exist.
In conclusion, we suggest a model in which the loss of p38
activity in the embryo leads to a reduction of XMyf5
expression. During gastrula–neurula stages, the loss of XMyf5
protein prevents cell cycle arrest, which leads to reduced
convergent extension in the paraxial mesoderm. At later
neurula–early tailbud stages (stages 16–22), there is a slight
delay in segmentation. By later tailbud stages (stage 25 and
onwards), there is a general deterioration of the somite borders
and structure. There is massive apoptosis in the ventral somites,
with a concomitant loss of pax3 expressing cells leading to
poor body wall muscle formation. Future experiments should
shed light on the upstream and downstream factors modifying
p38 signaling and XMyf5 expression in the developing
Xenopus mesoderm.
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